Top

Published in:

01-09-2008 | Parkinson's Disease and Allied Conditions - Original Article

Clinical characteristics of Parkinson’s disease among Jewish Ethnic groups in Israel

Authors: R. Djaldetti, S. Hassin-Baer, M. J. Farrer, C. Vilariño-Güell, O. A. Ross, V. Kolianov, S. Yust-Katz, T. A. Treves, Y. Barhum, M. Hulihan, E. Melamed

Published in: Journal of Neural Transmission | Issue 9/2008

Abstract

Yemenite Jews in Israel are a distinctive ethnic division of the Jewish diaspora. Clinical findings, disease course and genetic tests for the LRRK2 6055G > A (G2019S) mutation were compared between Ashkenazi and Yemenite Israeli patients with Parkinson’s disease (PD). Age of onset was significantly younger in the Yemenites (P < 0.001). There were no differences in the distribution of initial symptoms, environmental risk factors or rate of motor/non-motor phenomena. The Yemenite group had a more severe disease (P < 0.001), and a more rapid disease course (P = 0.006). The frequency of Lrrk2 substitution was 12.7% in the Ashkenazi group and was not observed in the Yemenites. These results show that there are differences between Israeli Jewish ethnic groups in the severity and progression of PD, but not in clinical symptoms. The high frequency of Lrrk2 G2019S in the Ashkenazi and its absence in the Yemenite Jews suggests a specific ancestral pattern of inheritance in Ashkenazi Jews.

Benmoyal-Segal L, Soreq H (2006) Gene-environment interactions in sporadic Parkinson’s disease. J Neurochem 97:1740–1755PubMedCrossRef

Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K (2006) Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology 67:1786–1791PubMedCrossRef

Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J (2006) Genetic analysis of LRRK2 mutations in patients with Parkinson disease. J Neurol Sci 251:102–106PubMedCrossRef

Djarmati A, Hedrich K, Svetel M, Schäfer N, Juric V, Vukosavic S, Hering R, Riess O, Romac S, Klein C, Kostic V (2004) Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 23:525PubMedCrossRef

Eastjam JH, Lacro JP, Jeste DV (1996) Ethnicity and movement disorders. Mt Sinai J Med 63:314–319

Goldberg-Stern H, Djaldetti R, Melamed E, Machado-Joseph Gadoth N (1994) (Azorean) disease in a Yemenite Jewish family in Israel. Neurology 44:1298–1231PubMed

Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ (1999) Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson’s disease. Neurotoxicology 20:239–247PubMed

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatr 55:181–184PubMedCrossRef

Inzelberg R, Schecthman E, Paleacu D, Zach L, Bonwitt R, Carasso RL, Nisipeanu P (2004) Onset and progression of disease in familial and sporadic Parkinson’s disease. Am J Med Genet A 124:255–258CrossRef

Kamel F, Tanner C, Umbach D et al (2007) Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol 165:364–374PubMedCrossRef

Kessler I (1972) Epidemiologic studies of Parkinson’s disease: iii. A community-based survey. Am J Epidemiol 96:242–254PubMed

Kunugi H, Nanko S, Ueki A, Otsuka E, Hattori M, Hoda F, Vallada HP, Arranz MJ, Collier DA (1997) High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson’s disease. Neurosci Lett 221:202–204PubMedCrossRef

Li X, Kitami T, Wang M, Mizuno Y, Hattori N (2005) Geographic and ethnic differences in frequencies of two polymorphisms (D/N394 and L/1272 of the parkin gene in sporadic Parkinson’s disease. Parkinsonism Relat Disord 11:485–491PubMedCrossRef

Marder K, Logroscino G, Alfaro B, Mejia H, Halim A, Louis E, Cote L, Mayeux R (1998) Environmental risk factors for Parkinson’s disease in an urban multiethnic community. Neurology 50:279–281PubMed

Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B et al (1995) The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988–1993. Am J Epidemiol 142:820–827PubMed

Mereu GP, Pacitti C, Argiolas A (1983) Effect of (−)-cathinone, a khat leaf constituent, on dopaminergic firing and dopamine metabolism in the rat brain. Life Sci 21(32)1383–1389

Nielsen JA (1985) Cathinone affects dopamine and 5-hydroxytryptamine neurons in vivo as measured by changes in metabolites and synthesis in four forebrain regions in the rat. Neuropharmacology 24:845–852PubMedCrossRef

Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N (2007) The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology 69:1595–1602PubMedCrossRef

Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB (2006) LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews. N Engl J Med 354:424–425PubMedCrossRef

Petrovitch H, Ross GW, Abbott RD, Sanderson WT, Sharp DS, Tanner CM, Masaki KH, Blanchette PL, Popper JS, Foley D, Launer L, White LR (2002) Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol 59:1787–1792PubMedCrossRef

Schoenberg BS, Osuntokun BO, Adeuja AO, Bademosi O, Nottidge V, Anderson DW, Haerer AF (1988) Comparison of the prevalence of Parkinson’s disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 38:645–646PubMed

Schulte PA, Burnett CA, Boeniger MF, Johnson J (1996) Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. Am J Public Health 86:1281–1288PubMedCrossRef

Semchuk KM, Love EJ, Lee RG (1992) Parkinson’s disease and exposure to agricultural work and pesticide chemicals. Neurology 42:1328–1335PubMed

Tan EK, Tan C, Zhao Y, Yew K, Shen H, Chandran VR, Teoh ML, Yih Y, Pavanni R, Wong MC (2004a) Genetic analysis of DJ-1 in a cohort Parkinson’s disease patients of different ethnicity. Neurosci Lett 367:109–112PubMedCrossRef

Tan LC, Venketasubramanian N, Hong CY, Sahadevan S, Chin JJ, Krishnamoorthy ES, Tan AK, Saw SM (2004b) Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians. Neurology 62:1999–2004PubMed

Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015–1022CrossRef

van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH Jr, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72:804–811PubMedCrossRef

Wermuth L, Bünger N, Von Weitzel-Mudersback P, Pakkenberg H, Jeune B (2004) Clinical characteristics of Parkinson’s disease among Inuit Greenland and inhabitants of the Faroe Islands and Als (Denmark). Mov Disord 19:821–824PubMedCrossRef

Willis AS, Freeman ML, Summar SR, Barr FE, Williams SM, Dawson E, Summar ML (2003) Ethnic diversity in a critical gene responsible for glutathione synthesis. Free Rad Biol Med 34:72–76PubMedCrossRef

Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H (2006) LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 79:752–758PubMedCrossRef

Zhang ZX, Román GC (1993) Worldwide occurrence of Parkinson’s disease: an updated review. Neuroepidemiology 12:195–208PubMedCrossRef

Title: Clinical characteristics of Parkinson’s disease among Jewish Ethnic groups in Israel
Authors: R. Djaldetti
S. Hassin-Baer
M. J. Farrer
C. Vilariño-Güell
O. A. Ross
V. Kolianov
S. Yust-Katz
T. A. Treves
Y. Barhum
M. Hulihan
E. Melamed
Publication date: 01-09-2008
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 9/2008
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-008-0074-z

At a glance: The STEP trials

Springer Medicine

Clinical characteristics of Parkinson’s disease among Jewish Ethnic groups in Israel

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2008

The effects of 1 Hz rTMS over the hand area of M1 on movement kinematics of the ipsilateral hand

Oxytocin inhibits the stimulatory effect of ghrelin on circulating neuropeptide Y levels in humans

l-dopa modulates motor cortex excitability in Alzheimer’s disease patients

Downhill training upregulates mice hippocampal and striatal brain-derived neurotrophic factor levels

Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus of rats: comparison to intracerebroventricular streptozotocin

Age-dependent changes in neuronal distribution of CacyBP/SIP: comparison to tubulin and the tau protein